Annual Shareholders Equity
$783.20 M
-$102.60 M-11.58%
01 December 2023
Summary:
Myriad Genetics annual stockholders equity is currently $783.20 million, with the most recent change of -$102.60 million (-11.58%) on 01 December 2023. During the last 3 years, it has fallen by -$97.80 million (-11.10%). MYGN annual shareholders equity is now -28.07% below its all-time high of $1.09 billion, reached on 30 June 2019.MYGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$731.70 M
-$8.80 M-1.19%
01 September 2024
Summary:
Myriad Genetics quarterly stockholders equity is currently $731.70 million, with the most recent change of -$8.80 million (-1.19%) on 01 September 2024. Over the past year, it has dropped by -$51.50 million (-6.58%). MYGN quarterly shareholders equity is now -33.61% below its all-time high of $1.10 billion, reached on 30 September 2018.MYGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYGN Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -6.6% |
3 y3 years | -11.1% | -24.5% |
5 y5 years | -28.1% | -31.9% |
MYGN Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -19.1% | at low | -24.5% | +7.1% |
5 y | 5 years | -28.1% | at low | -32.1% | +7.1% |
alltime | all time | -28.1% | +1524.9% | -33.6% | +1418.0% |
Myriad Genetics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $731.70 M(-1.2%) |
June 2024 | - | $740.50 M(-2.6%) |
Mar 2024 | - | $760.00 M(-3.0%) |
Dec 2023 | $783.20 M(-11.6%) | $783.20 M(+14.6%) |
Sept 2023 | - | $683.40 M(-7.0%) |
June 2023 | - | $735.20 M(-12.0%) |
Mar 2023 | - | $835.20 M(-5.7%) |
Dec 2022 | $885.80 M(-8.5%) | $885.80 M(-3.4%) |
Sept 2022 | - | $916.60 M(-3.3%) |
June 2022 | - | $947.40 M(-0.3%) |
Mar 2022 | - | $950.10 M(-1.8%) |
Dec 2021 | $967.80 M(+9.9%) | $967.80 M(-0.1%) |
Sept 2021 | - | $968.60 M(+7.3%) |
June 2021 | - | $902.50 M(+3.1%) |
Mar 2021 | - | $875.20 M(-3.8%) |
Dec 2020 | $881.00 M(-4.1%) | - |
Sept 2020 | - | $909.30 M(-1.0%) |
June 2020 | $918.20 M(-15.7%) | $918.20 M(-5.1%) |
Mar 2020 | - | $967.20 M(-10.2%) |
Dec 2019 | - | $1.08 B(+0.3%) |
Sept 2019 | - | $1.07 B(-1.3%) |
June 2019 | $1.09 B(+12.7%) | $1.09 B(+0.7%) |
Mar 2019 | - | $1.08 B(+1.7%) |
Dec 2018 | - | $1.06 B(-3.4%) |
Sept 2018 | - | $1.10 B(+14.1%) |
June 2018 | $966.10 M(+25.7%) | $966.10 M(+1.9%) |
Mar 2018 | - | $948.30 M(+3.7%) |
Dec 2017 | - | $914.20 M(+5.0%) |
Sept 2017 | - | $870.90 M(+13.3%) |
June 2017 | $768.40 M(+2.7%) | $768.40 M(+2.7%) |
Mar 2017 | - | $748.20 M(+2.1%) |
Dec 2016 | - | $732.90 M(-0.4%) |
Sept 2016 | - | $735.50 M(-1.7%) |
June 2016 | $748.10 M(+13.0%) | $748.10 M(-2.9%) |
Mar 2016 | - | $770.20 M(-0.1%) |
Dec 2015 | - | $770.80 M(+12.2%) |
Sept 2015 | - | $687.10 M(+3.8%) |
June 2015 | $662.10 M(-7.9%) | $662.10 M(-1.0%) |
Mar 2015 | - | $668.90 M(-3.7%) |
Dec 2014 | - | $694.24 M(-2.5%) |
Sept 2014 | - | $712.15 M(-1.0%) |
June 2014 | $719.00 M(-1.3%) | $719.00 M(-0.4%) |
Mar 2014 | - | $722.24 M(+6.8%) |
Dec 2013 | - | $675.97 M(-2.1%) |
Sept 2013 | - | $690.27 M(-5.3%) |
June 2013 | $728.59 M(+14.6%) | $728.59 M(+9.6%) |
Mar 2013 | - | $664.93 M(+0.4%) |
Dec 2012 | - | $662.12 M(+4.2%) |
Sept 2012 | - | $635.57 M(-0.0%) |
June 2012 | $635.66 M(+12.2%) | $635.66 M(-2.5%) |
Mar 2012 | - | $652.19 M(+5.7%) |
Dec 2011 | - | $616.76 M(+6.5%) |
Sept 2011 | - | $578.99 M(+2.2%) |
June 2011 | $566.79 M(+1.7%) | $566.79 M(+8.1%) |
Mar 2011 | - | $524.46 M(-6.5%) |
Dec 2010 | - | $561.10 M(-1.8%) |
Sept 2010 | - | $571.11 M(+2.4%) |
June 2010 | $557.58 M | $557.58 M(-1.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $567.35 M(+9.7%) |
Dec 2009 | - | $517.33 M(+9.3%) |
Sept 2009 | - | $473.14 M(+9.0%) |
June 2009 | $434.22 M(+2.0%) | $434.22 M(-25.6%) |
Mar 2009 | - | $583.93 M(+12.3%) |
Dec 2008 | - | $519.75 M(+9.0%) |
Sept 2008 | - | $477.04 M(+12.1%) |
June 2008 | $425.65 M(+25.1%) | $425.65 M(+20.5%) |
Mar 2008 | - | $353.30 M(+1.1%) |
Dec 2007 | - | $349.47 M(+2.3%) |
Sept 2007 | - | $341.75 M(+0.4%) |
June 2007 | $340.36 M(+36.3%) | $340.36 M(+0.3%) |
Mar 2007 | - | $339.19 M(+43.8%) |
Dec 2006 | - | $235.85 M(-1.7%) |
Sept 2006 | - | $239.87 M(-4.0%) |
June 2006 | $249.78 M(+84.1%) | $249.78 M(-2.7%) |
Mar 2006 | - | $256.70 M(-1.9%) |
Dec 2005 | - | $261.65 M(+104.9%) |
Sept 2005 | - | $127.69 M(-5.9%) |
June 2005 | $135.67 M(-21.7%) | $135.67 M(-5.8%) |
Mar 2005 | - | $144.04 M(-6.5%) |
Dec 2004 | - | $154.00 M(-5.9%) |
Sept 2004 | - | $163.62 M(-5.6%) |
June 2004 | $173.28 M(+6.0%) | $173.28 M(+29.8%) |
Mar 2004 | - | $133.49 M(-7.4%) |
Dec 2003 | - | $144.10 M(-6.3%) |
Sept 2003 | - | $153.77 M(-5.9%) |
June 2003 | $163.49 M(+26.9%) | $163.49 M(-3.8%) |
Mar 2003 | - | $170.00 M(-3.1%) |
Dec 2002 | - | $175.44 M(+41.5%) |
Sept 2002 | - | $124.02 M(-3.8%) |
June 2002 | $128.87 M(-7.7%) | $128.87 M(-4.4%) |
Mar 2002 | - | $134.74 M(-2.8%) |
Dec 2001 | - | $138.57 M(-0.5%) |
Sept 2001 | - | $139.27 M(-0.2%) |
June 2001 | $139.56 M(+79.6%) | $139.56 M(+0.2%) |
Mar 2001 | - | $139.23 M(-0.4%) |
Dec 2000 | - | $139.78 M(+42.3%) |
Sept 2000 | - | $98.20 M(+26.4%) |
June 2000 | $77.71 M(+61.2%) | $77.71 M(+40.6%) |
Mar 2000 | - | $55.25 M(-0.4%) |
Dec 1999 | - | $55.50 M(+9.3%) |
Sept 1999 | - | $50.80 M(+5.4%) |
June 1999 | $48.20 M(-16.2%) | $48.20 M(-4.4%) |
Mar 1999 | - | $50.40 M(-4.0%) |
Dec 1998 | - | $52.50 M(-4.5%) |
Sept 1998 | - | $55.00 M(-4.3%) |
June 1998 | $57.50 M(-13.1%) | $57.50 M(-4.6%) |
Mar 1998 | - | $60.30 M(-4.0%) |
Dec 1997 | - | $62.80 M(-2.8%) |
Sept 1997 | - | $64.60 M(-2.4%) |
June 1997 | $66.20 M(-5.7%) | $66.20 M(+7.6%) |
Mar 1997 | - | $61.50 M(-4.4%) |
Dec 1996 | - | $64.30 M(-4.9%) |
Sept 1996 | - | $67.60 M(-3.7%) |
June 1996 | $70.20 M | $70.20 M(-2.2%) |
Mar 1996 | - | $71.80 M(-2.2%) |
Dec 1995 | - | $73.40 M |
FAQ
- What is Myriad Genetics annual stockholders equity?
- What is the all time high annual shareholders equity for Myriad Genetics?
- What is Myriad Genetics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Myriad Genetics?
- What is Myriad Genetics quarterly shareholders equity year-on-year change?
What is Myriad Genetics annual stockholders equity?
The current annual shareholders equity of MYGN is $783.20 M
What is the all time high annual shareholders equity for Myriad Genetics?
Myriad Genetics all-time high annual stockholders equity is $1.09 B
What is Myriad Genetics quarterly stockholders equity?
The current quarterly shareholders equity of MYGN is $731.70 M
What is the all time high quarterly shareholders equity for Myriad Genetics?
Myriad Genetics all-time high quarterly stockholders equity is $1.10 B
What is Myriad Genetics quarterly shareholders equity year-on-year change?
Over the past year, MYGN quarterly stockholders equity has changed by -$51.50 M (-6.58%)